Intralipid in Prophylaxis of Amphotericin B Nephrotoxicity

Abstract

Get full access to this article

View all access options for this article.

References

Gallis

Drew

Picard

. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12: 308–28.

Butler

Bennett

Alling

Wertlake

Utz

Hill

III . Nephrotoxicity of amphotericin B: Early and late effects in 81 patients. Ann Intern Med 1964; 61: 175–87.

Takacs

Tomkiewics

Merill

. Amphotericin B nephrotoxicity with irreversible renal failure. Ann Intern Med 1963; 59: 716–24.

Gardner

Godley

Wasan

. Sodium loading treatment for amphotericin B-induced nephrotoxicity. DICP Ann Pharmacother 1990; 24: 940–6.

Ohnishi

Stevenhead

Robinson

Glick

O'Day

, Sodium status influences chronic amphotericin B nephrotoxicity in rats. Antimicrob Agents Chemother 1989; 33: 1222–7.

Gondal

Swartz

Raliman

Aquilur

. Therapeutic evaluations of free and lysosome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob Agents Chemother 1989; 33: 1544–8.

Janknegt

De Marie

Bakker-Woudenberg

Crommelin

. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet 1992; 23: 279–91.

Juliano

Grant

Barber

Kalp

. Mechanism of the toxicity of amphotericin B incorporated into liposomes. Mol Pharmacol 1987; 31: 1–11.

Abu-Salah

. Alteration of permeability of the human erythrocyte membrane to cation by liposome-incorporated amphotericin B. Eur J Clin Chem Clin Biochem 1992; 30: 737–44.

10.

Brajurb

Powderly

Kobayashi

Medoff

. Amphotericin B: Delivery systems. Antimicrob Agents Chemother 1990; 34: 381–4.

11.

Kirsh

Goldstein

Tarloff

Davis

Hook

Hanna

, An emulsion formulation of amphotericin B improves therapeutic index when treating systemic murine candidiasis. J Infect Dis 1988; 158: 1065–70.

12.

Moreau

Milped

Fayette

Ramee

Harousseau

. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with amphotericin B in neutropenic patients. J Antimicrob Chemotherapy 1992; 30: 535–41.

13.

Chavanet

Garry

Charlier

Calliot

Kisterman

D'Athis

, Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. BMJ 1992; 305: 921–5.

14.

Amphotericin B. In: Kucer

Bennett

NMcK

, eds. The use of antibiotics. 4th ed. Philadelphia: J.B. Lippincott, 1987: 1441–77.

15.

Korman

. Pemphigus. J Am Acad Dermatol 1988; 18: 1219–38.

16.

Bystryn

. Adjuvant therapy of pemphigus. Arch Dermatol 1984; 120: 941–51.

17.

Zloty

. Immunosuppressive agents in dermatology. Dermatol Clin 1993; 11: 73–85.

18.

Groisser

Griffiths

CEM

Ellis

Voorhees

. A review and update of the clinical uses of cyclosporine in dermatology. Dermatol Clin 1991; 9: 805–17.

19.

Thivolet

Barthelemy

Rigot-Muller

Bendelac

. Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet 1985; 1: 334–5.

20.

Barthelemy

Frappaz

Cambazard

Mauduit

Rouchouse

Kanitakis

, Treatment of nine cases of pemphigus vulgaris with cyclosporine. J Am Acad Dermatol 1988; 18: 1262–6.

21.

Alijotas

Pedragosa

Bosch

Vilardell

. Prolonged remission after cyclosporine therapy in pemphigus vulgaris: Report of two young siblings. J Am Acad Dermatol 1990; 23: 701–3.

22.

Bondesson

Hammar

. Treatment of pemphigus vulgaris with cyclosporine. Dermatologica 1990; 181: 308–10.

23.

Gupta

Ellis

Nickoloff

Goldfarb

Rocher

, Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses: A clinical and immunopathologic analysis. Arch Dermatol 1990; 126: 339–50.

24.

Eisen

Ellis

Voorhees

. Topical cyclosporine for oral bullous disorders. J Am Acad Dermatol 1990; 23: 936–7.

25.

Pemberton

. Oesophageal obstruction and ulceration caused by oral potassium therapy. Br Heart J 1970; 32: 267–8.

26.

Kikendall

Friedman

Oyewole

Fleischer

Johnson

. Pill-induced esophageal injury. Case report and review of the medical literature. Dig Dis Sci 1983; 28: 174–82.

27.

Bokey

Hugh

. Oesophageal ulceration associated with doxycycline therapy. Med J Aust 1975; 1: 236–7.

28.

Amendola

Spera

. Doxycycline-induced esophagitis. JAMA 1985; 253: 1009–11.

29.

Crowson

Head

Ferrante

. Esophageal ulcers associated with tetracycline therapy. JAMA 1976; 235: 2747–8.

30.

Schneider

. Doxycycline esophageal ulcers. Dig Dis Sci 1977; 22: 805–7.

31.

Biller

Flores

Buie

Mazor

Katz

. Tetracycline-induced esophagitis in adolescent patients. J Pediatr 1992; 120: 144–5.

32.

Geschwind

. Oesophagitis and oesophageal ulceration following ingestion of doxycycline tablets (letter). Med J Aust 1984; 140: 223.

33.

Hatheway

. Doxycycline-induced esophagitis. Drug Intell Clin Pharm 1982; 16: 879–80.

34.

Agha

Wilson

Nostrand

. Medication-induced esophagitis. Gastrointest Radiol 1986; 11: 7–11.

35.

Pinos

Figueras

Mas

. Doxycycline-induced esophagitis: Treatment with liquid sucralphate (letter). Am J Gastroenterol 1990; 85: 902–3.

36.

O'Meara

. A new endoscopic finding of tetracycline-induced esophageal ulcers. Gastrointest Endoscopy 1980; 26: 106–7.

37.

Jones

. Adverse drug reactions in the community health setting: Approaches to recognizing, counseling and reporting. Fam Commun Health 1982; 5 (2): 58–67.

38.

Bott

Prakash

McCallum

. Medication-induced esophageal injury: Survey of the literature. Am J Gastroenterol 1987; 82: 758–63.

39.

Eng

Sabanathan

. Drug-induced esophagitis. Am J Gastroenterol 1991; 86: 1127–33.

40.

Carlborg

Densert

Lindqvist

. Tetracycline induced esophageal ulcers: A clinical and experimental study. Laryngoscope 1983; 93: 184–7.

41.

Mason

O'Meara

. Drug-induced esophagitis. J Clin Gastroenterol 1981; 3: 115–20.

42.

Ovartlarnporn

Kulwichit

Hiranniramol

. Medication-induced esophageal injury: Report of 17 cases with endoscopic documentation. Am J Gastroenterol 1991; 86: 748–50.

43.

Bailey

Jr Bonavina

Nwakama

Demeester

Cheng

. Influence of dissolution rate and pH of oral medications on drug-induced esophageal injury. DICP Ann Pharmacother 1990; 24: 571–4.

44.

Chandy

Rolston

. Doxycycline-induced esophageal ulceration: Do old capsules play a role? (letter) J Clin Gastroenterol 1987; 9: 113.

45.

Dent

Dodds

Friedman

Sekiguchi

Hogan

Arndorfer

, Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980; 65: 256–67.

46.

Orr

Johnson

Robinson

. Effect of sleep on swallowing, esophageal peristalsis and acid clearance. Gastroenterology 1984; 86: 814–9.

47.

Helm

Dodds

Riedel

Teeter

Hogan

Arndorfer

. Determinants of esophageal acid clearance in normal subjects. Gastroenterology 1983; 85: 607–12.

48.

Channer

Virjee

. Effect of posture and drink volume on the swallowing of capsules. Br Med J 1982; 285: 1702.

49.

Hey

Jorgensen

Sorensen

Hasselbalch

Wamberg

. Oesophageal transit of six commonly used tablets and capsules. Br Med J 1982; 285: 1717–9.

50.

Teplick

Ominsky

Haskin

. Esophagitis caused by oral medication. Radiology 1980; 134: 23–5.